[
  {
    "ts": null,
    "headline": "Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower inte",
    "url": "https://finnhub.io/api/news?id=b8a498c5b9504799a2af24a1006f12e491ae7b4bb7bece925564c5c98ada1044",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755022853,
      "headline": "Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know",
      "id": 136321954,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower inte",
      "url": "https://finnhub.io/api/news?id=b8a498c5b9504799a2af24a1006f12e491ae7b4bb7bece925564c5c98ada1044"
    }
  },
  {
    "ts": null,
    "headline": "Guggenheim Lifts PT on Regeneron Pharmaceuticals (REGN) to $815 From $810",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the top most undervalued biotech stocks to buy now. Guggenheim analyst Yatin Suneja raised the firm’s price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $815 from $810 on August 4, keeping a Buy rating on the shares. The analyst told investors in a post-earnings note that the company’s […]",
    "url": "https://finnhub.io/api/news?id=ad37a30774f862f6070384645756b8596898ad1ca1330df7c95af30290a9fe16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755004252,
      "headline": "Guggenheim Lifts PT on Regeneron Pharmaceuticals (REGN) to $815 From $810",
      "id": 136320857,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the top most undervalued biotech stocks to buy now. Guggenheim analyst Yatin Suneja raised the firm’s price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $815 from $810 on August 4, keeping a Buy rating on the shares. The analyst told investors in a post-earnings note that the company’s […]",
      "url": "https://finnhub.io/api/news?id=ad37a30774f862f6070384645756b8596898ad1ca1330df7c95af30290a9fe16"
    }
  },
  {
    "ts": null,
    "headline": "Sanofi halts Praluent supply in China due to limited availability",
    "summary": "Investing.com -- Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability of the popular cholesterol medication.",
    "url": "https://finnhub.io/api/news?id=d2b63f6790827e4dba54321f699fc62cf4916b7b953d874c9c396b2b933e2566",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754994972,
      "headline": "Sanofi halts Praluent supply in China due to limited availability",
      "id": 136316317,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Investing.com -- Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability of the popular cholesterol medication.",
      "url": "https://finnhub.io/api/news?id=d2b63f6790827e4dba54321f699fc62cf4916b7b953d874c9c396b2b933e2566"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Reveals The Regeneron Prize For Creative Innovation 2025 Winners",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) awarded the 13th annual Regeneron Prize for Creative Innovation to early-career biomedical researchers who displayed exceptional innovation. The winners for 2025 are Dr. Alissandra L. Hillis, a postdoctoral fellow at MIT, and Mr. Sreekar […]",
    "url": "https://finnhub.io/api/news?id=dc8da4afc6658a8c3196764d20213d7e58505882daaf1bea6b8581a3214851fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754958025,
      "headline": "Regeneron Reveals The Regeneron Prize For Creative Innovation 2025 Winners",
      "id": 136316318,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) awarded the 13th annual Regeneron Prize for Creative Innovation to early-career biomedical researchers who displayed exceptional innovation. The winners for 2025 are Dr. Alissandra L. Hillis, a postdoctoral fellow at MIT, and Mr. Sreekar […]",
      "url": "https://finnhub.io/api/news?id=dc8da4afc6658a8c3196764d20213d7e58505882daaf1bea6b8581a3214851fd"
    }
  }
]